Event Group

Event Group

Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.

Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.

Event Group path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Group

Event Group


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2025-12-26 @ 3:50 AM
NCT ID: NCT05202418
Group ID: EG000
Title: Biofeedback Enhanced Treatment
Description: Participants will engage in biofeedback-enhanced, cognitive-behavioral coping skills treatment. Sessions will include brief, daily homework assignments tailored to youth (e.g., using apps for skill practice). Participants will complete pre- and post-session questionnaires to assess autonomic reactivity, lifetime stress, depression, anxiety, and coping strategies in response to stress induction. Biofeedback Enhanced Treatment: The intervention involves biofeedback enhanced cognitive behaviorally based coping skills treatment. Treatment will consist of a 6-visit group intervention conducted online, via Emory Zoom. Groups will include 5-8 patients each. Sessions will include brief, daily homework to facilitate mastery, developmentally tailored to youth (e.g., practice skills with support from phone or tablet apps). Groups will meet approximately every week for 6 weeks. Advanced Ph.D. students in clinical psychology and the Principal Investigator will deliver the treatment protocol. Participants will complete questionnaires before and after each session to measure autonomic reactivity, lifetime stress, depression, anxiety in response to stress induction, and coping strategies.
Deaths Number Affected: 0
Deaths Number At Risk: None
Serious Number Affected: 0
Serious Number At Risk: 24
Other Number Affected: 0
Other Number At Risk: 24
Study: NCT05202418
Results Section: NCT05202418
Adverse Events Module: NCT05202418